← FDA Drug Approvals (Drugs@FDA)
PRALATREXATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2016-01-21
Drug application
- FDA Application #
ANDA206167- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PRALATREXATE
- Generic name
- Pralatrexate
- Active ingredients
- PRALATREXATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2016-01-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown